Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Ali T Taher, Sally Temraz & M Domenica Cappellini. (2013) Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia. Expert Review of Hematology 6:5, pages 495-509.
Read now
Read now
Galila M. Mokhtar, Mohsen Gadallah, Nayera H.K. El Sherif & Heba T.A. Ali. (2013) Morbidities and Mortality in Transfusion-Dependent Beta-Thalassemia Patients (Single-Center Experience). Pediatric Hematology and Oncology 30:2, pages 93-103.
Read now
Read now
Krittapoom Akrawinthawong, Nithima Chaowalit, Thanasaporn Chatuparisuth & Noppadol Siritanaratkul. (2011) Effectiveness of deferiprone in transfusion‐independent beta‐thalassemia/HbE patients. Hematology 16:2, pages 113-122.
Read now
Read now
Dimitrios Tsiapras, Soso Fragatou, Kalistheni Farmaki, Stamatios Kyrzopoulos, Ioannis Paraskevaidis, Vasilios Voudris & Dimitrios Kremastinos. (2010) Effect of Combined Chelation Therapy with Deferiprone and Deferoxamine on Left Ventricular Diastolic Function in Adult β-Thalassemia Major Patients. Hemoglobin 34:3, pages 210-220.
Read now
Read now
Ching-Tien Peng, Jeng-Sheng Chang, Lin-Yen Wang, Shyh-Shin Chiou, Chih-Cheng Hsiao, Shih-Chung Wang, Giun-Yi Hung & Kang-Hsi Wu. (2009) Update on Thalassemia Treatment in Taiwan, Including Bone Marrow Transplantation, Chelation Therapy, and Cardiomyopathy Treatment Effects. Hemoglobin 33:5, pages 304-311.
Read now
Read now
Annita Kolnagou, Yiannis Michaelides, Christos Kontos, Kyriacos Kyriacou & George J. Kontoghiorghes. (2008) Myocyte Damage and Loss of Myofibers is the Potential Mechanism of Iron Overload Toxicity in Congestive Cardiac Failure in Thalassemia. Complete Reversal of the Cardiomyopathy and Normalization of Iron Load by Deferiprone. Hemoglobin 32:1-2, pages 17-28.
Read now
Read now
Ching-Tien Peng, Chang-Hai Tsai & Kang-Hsi Wu. (2008) Effects of Chelation Therapy on Cardiac Function Improvement in Thalassemia Patients: Literature Review and the Taiwanese Experience. Hemoglobin 32:1-2, pages 49-62.
Read now
Read now
Articles from other publishers (5)
Han-Ping Wu, Cheng-Li Lin, Yin-Chen Chang, Kang-Hsi Wu, Rouh-Lih Lei, Ching-Tien Peng, Tefu Weng, Yu-Man Tai & Yu-Hua Chao. (2017) Survival and complication rates in patients with thalassemia major in Taiwan. Pediatric Blood & Cancer 64:1, pages 135-138.
Crossref
Crossref
Sarmishtha Chatterjee, Shuvasree Sarkar & Shelley Bhattacharya. (2014) Toxic Metals and Autophagy. Chemical Research in Toxicology 27:11, pages 1887-1900.
Crossref
Crossref
Marcello Marcí, Lorella Pitrolo, Carmela Lo Pinto, Nicola Sanfilippo & Roberto Malizia. (2011) Detection of Early Cardiac Dysfunction in Patients with Beta Thalassemia by Tissue Doppler Echocardiography. Echocardiography 28:2, pages 175-180.
Crossref
Crossref
Heather A. Leitch. (2011) Optimizing Therapy for Iron Overload in the Myelodysplastic Syndromes. Drugs 71:2, pages 155-177.
Crossref
Crossref
Ching-Tien Peng, Chang-Hai Tsai, Kang-Hsi Wu, Chih-Chao Hsu & Tao-Yu Sheng. (2007) Improvement of Cardiac Function in Thalassemia Patients Using Deferiprone. Tzu Chi Medical Journal 19:4, pages 192-199.
Crossref
Crossref